ask="3.47"
ask_size="3500"
average_daily_volume="2983580"
bid="3.40"
bid_size="100"
book_value="0.61"
change="+0.24"
change_from_200_day_moving_average="2.31"
change_from_50_day_moving_average="1.84"
change_from_52_week_high="-1.01"
change_From_52_week_low="2.69"
change_in_percent="+7.79%"
close="3.32"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.65"
ebitda="-42.12M"
eps_estimate_current_year="-1.50"
eps_estimate_next_quarter="-0.31"
eps_estimate_next_year="-1.45"
ex_dividend_date="N/A"
float_shares="18031000"
high="3.58"
high_52_weeks="4.33"
last_trade_date="3/17/2017"
last_trade_price="3.32"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.80"
low_52_weeks="0.63"
market_capitalization="91.08M"
moving_average_200_day="1.01"
moving_average_50_day="1.48"
name="Cerulean Pharma Inc."
notes="N/A"
one_year_target_price="3.75"
open="3.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+230.06%"
percent_change_from_50_day_moving_average="+124.03%"
percent_change_from_52_week_high="-23.33%"
percent_change_from_52_week_low="+426.73%"
previous_close="3.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.07"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="27435000"
short_ratio="0.44"
stock_exchange="NGM"
symbol="CERU"
volume="10117588"
weeks_range_52="0.63 - 4.33"
